期刊
BMC PULMONARY MEDICINE
卷 21, 期 1, 页码 -出版社
BMC
DOI: 10.1186/s12890-020-01376-4
关键词
Pneumonitis; Radiation pneumonitis; Radiation-induced lung injury; Lung cancer; Radiotherapy; Antineoplastic agents; Adverse effects
Pneumonitis, including Radiation Pneumonitis and Radiation Fibrosis, can be life-threatening adverse pulmonary effects caused by various factors. Pulmonary function tests play a significant role in evaluating lung function status during treatment and preventing complications.
Chemo-radiotherapy and systemic therapies have proven satisfactory outcomes as standard treatments for various thoracic malignancies; however, adverse pulmonary effects, like pneumonitis, can be life-threatening. Pneumonitis is caused by direct cytotoxic effect, oxidative stress, and immune-mediated injury. Radiotherapy Induced Lung Injury (RILI) encompasses two phases: an early phase known as Radiation Pneumonitis (RP), characterized by acute lung tissue inflammation as a result of exposure to radiation; and a late phase called Radiation Fibrosis (RF), a clinical syndrome that results from chronic pulmonary tissue damage. Currently, diagnoses are made by exclusion using clinical assessment and radiological findings. Pulmonary function tests have constituted a significant step in evaluating lung function status during radiotherapy and useful predictive tools to avoid complications or limit toxicity. Systemic corticosteroids are widely used to treat pneumonitis complications, but its use must be standardized, and consider in the prophylaxis setting given the fatal outcome of this adverse event. This review aims to discuss the clinicopathological features of pneumonitis and provide practical clinical recommendations for prevention, diagnosis, and management.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据